Affiliation: University Hospital
- Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantationGeorg M Fröhlich
Cardiovascular Division, University Hospital Zurich, Raemistrasse 100, Zurich CH 8091, Switzerland
Heart 99:1158-65. 2013..This study was designed to delineate the role of implantable cardioverter defibrillator (ICD) therapy for the primary and secondary prevention of sudden cardiac death in patients listed for heart transplantation...
- Evidence for improvement in survival with antihypertensive combination treatmentFrank Ruschitzka
Heart Failure Transplantation Clinic, University Clinic Zurich, Switzerland
J Hypertens 29:S9-14. 2011..The best clinical trial evidence comes from large outcome studies with an ACE inhibitor and dihydropyridine calcium antagonist combination, that of perindopril/amlodipine in the ASCOT trial in particular...
- Cardiovascular effects of flavanol-rich chocolate in patients with heart failureAndreas J Flammer
Cardiovascular Center, Cardiology University Hospital Zurich, Raemistrasse 100, Zurich, Switzerland
Eur Heart J 33:2172-80. 2012..As statins are ineffective in CHF, alternative therapies are a clinical need. We therefore investigated whether FRC might improve cardiovascular function in patients with CHF...
- Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over studyFrank Enseleit
Cardiovascular Center Cardiology, University Hospital Zurich, Ramistrasse 100, Zurich, Switzerland
Eur Heart J 33:1589-97. 2012..atlantica) that exerts antioxidative, anti-inflammatory, and anti-platelet effects. However, the effects of Pycnogenol on endothelial dysfunction, a precursor of atherosclerosis and cardiovascular events, remain still elusive...
- Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertensionAndreas J Flammer
Cardiovascular Center, Cardiology, University Hospital Zurich, Switzerland
J Hypertens 25:785-91. 2007..We investigated the influence of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension...
- Cocoa, blood pressure, and vascular functionIsabella Sudano
Cardiovascular Center Cardiology, University Hospital Zurich, Raemistrasse 100, CH 8091, Zurich, Switzerland
Curr Hypertens Rep 14:279-84. 2012..It is the aim of this review to summarize the findings of cocoa and chocolate on blood pressure and vascular function...
- Cholesterylestertransfer protein inhibition and endothelial function in type II hyperlipidemiaFrank Hermann
University Hospital Zurich, Zurich, Switzerland
Thromb Res 123:460-5. 2009....
- Dark chocolate improves coronary vasomotion and reduces platelet reactivityAndreas J Flammer
Cardiovascular Center, Cardiology, University Hospital Zurich, Raemistr 100, CH 8091 Zurich, Switzerland
Circulation 116:2376-82. 2007..Thus, flavonoid-rich dark chocolate holds the potential to have a beneficial impact on graft atherosclerosis...
- Nonsteroidal antiinflammatory drugs, acetaminophen, and hypertensionIsabella Sudano
Cardiovascular Center Cardiology, University Hospital Zurich, Ramistrasse 100, 8091, Zurich, Switzerland
Curr Hypertens Rep 14:304-9. 2012..selective COX inhibitors are currently underway. This review summarizes the current knowledge on the cardiovascular effects of NSAIDs and acetaminophen, and their potential clinical consequences...
- Coffee blunts mental stress-induced blood pressure increase in habitual but not in nonhabitual coffee drinkersIsabella Sudano
Cardiovascular Center, Cardiology, University Hospital Zurich, Zurich, Switzerland
Hypertension 46:521-6. 2005..Caffeine alone does not exert any potentiating effect, confirming that ingredients other than caffeine are partially responsible for the stimulating effect of coffee on the cardiovascular system...
- Takotsubo cardiomyopathy has a unique cardiac biomarker profile: NT-proBNP/myoglobin and NT-proBNP/troponin T ratios for the differential diagnosis of acute coronary syndromes and stress induced cardiomyopathyGeorg M Fröhlich
Cardiovascular Center Cardiology, University Hospital Zurich, Zurich, Switzerland
Int J Cardiol 154:328-32. 2012..It was our aim to identify TC by its unique cardiac biomarker profile at an early stage and, preferably, with non-invasive procedures only...
- Characteristics and long-term outcome of echocardiographic super-responders to cardiac resynchronisation therapy: 'real world' experience from a single tertiary care centreJan Steffel
Department of Cardiology, University Hospital Zurich, Ramistrasse 100, Zurich 8091, Switzerland
Heart 97:1668-74. 2011..The individual benefit from cardiac resynchronisation therapy (CRT) varies largely among patients...
- Haemodynamically irrelevant pericardial effusion is associated with increased mortality in patients with chronic heart failureGeorg M Fröhlich
Cardiovascular Center, Cardiology, University Hospital Zurich, Ramistrasse 100, Zurich CH 8091, Switzerland
Eur Heart J 34:1414-23. 2013..Pericardial effusion (PE) is a common finding in cardiac patients with chronic heart failure. The prognostic relevance of a small, haemodynamically non-compromising PE in such patients, however, remains to be determined...
- Cyclosporine C0- versus C2-monitoring over three years in maintenance heart transplantationMatthias Hermann
Cardiovascular Center Cardiology, University Hospital Zurich, Ramistrasse 100, 8091 Zurich, Switzerland
Swiss Med Wkly 141:w13149. 2011..In particular, data from long-term maintenance patients are not available...
- Upgrading to resynchronization therapy after chronic right ventricular pacing improves left ventricular remodellingGeorg Fröhlich
Cardiovascular Center, Cardiology, University Hospital Zurich, Raemistrasse 100, Zurich CH 8091, Switzerland
Eur Heart J 31:1477-85. 2010..Upgrading patients with chronic RV pacing to cardiac resynchronization therapy (CRT) may be considered to restore synchronicity and prevent these deleterious effects...
- Statins and the risk of cancer after heart transplantationGeorg Marcus Fröhlich
Cardiovascular Center Cardiology, Heart Failure Transplantation Clinic, University Hospital Zurich, Ramistrasse 100, CH 8091 Zurich, Switzerland
Circulation 126:440-7. 2012..Statins may have an impact on clinical outcomes beyond their lipid-lowering effects. The aim of the present study was to delineate whether statin therapy has an impact on cancer risk and total mortality after heart transplantation...
- NT-proBNP provides incremental prognostic information in cardiac outpatients with and without echocardiographic findingsStefan Toggweiler
Department of Cardiology, Cardiovascular Center, University Hospital Zurich, Zurich, Switzerland
Clin Cardiol 34:183-8. 2011..Outpatients frequently present with elevated natriuretic peptides in the absence of an obvious cardiac abnormality or with normal natriuretic peptides despite echocardiographic findings...
- Cardiac resynchronization therapy in patients with a narrow QRSJohannes Holzmeister
Cardiovascular Center, University Hospital Zurich, Ramistrasse 100, Zurich, Switzerland
Curr Heart Fail Rep 6:49-56. 2009..Such a trial, the EchoCRT trial, has recently been launched...
- Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugsMatthias Hermann
Cardiology, Cardiovascular Center, University Hospital Zurich, Switzerland
Ann Med 39:18-27. 2007....
- Images in cardiovascular medicine. The blue man: amiodarone-induced skin discolorationFrank Enseleit
Cardiovascular Center Cardiology, University Hospital Zurich, Zurich, Switzerland
Circulation 113:e63. 2006
- Cardiovascular effects of coffee: is it a risk factor?Isabella Sudano
Department of Internal Medicine, Cardiology Unit, University Hospital Zurich, Zurich, Switzerland
Prog Cardiovasc Nurs 20:65-9. 2005..In contrast to early studies, recent research indicates that habitual moderate coffee intake does not represent a health hazard and may even be associated with beneficial effects on cardiovascular health...
- Selective COX-2 inhibition improves endothelial function in coronary artery diseaseRemy Chenevard
Cardiovascular Center, Cardiology and Department of Rheumatology, University Hospital Zurich, Switzerland
Circulation 107:405-9. 2003....